Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-31

Clinical Trial Update: Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally [Phase 2]

View source ↗

Summary

Phase 2 trial comparing immunogenicity of inactivated poliovirus vaccine administered intramuscularly versus intradermally.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated Poliovirus Vaccine (Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Instituto Nacional de Saúde, Mozambique | Conditions: Polio | Phase 2 | Status: COMPLETED